Information about Immo-Pharm
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0726.954.523

VAT liability
No
Established
21-05-2019
Last balance sheet year
2025
Company size
Micro 0 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Buying and selling of own real estate
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Immo-Pharm

2025 2024 2023 2022
Income statement
Profit/Loss € 16,580 147% € 6,715 -59% € 16,313 43% € 11,387
Gross margin € 37,985 53% € 24,868 -29% € 34,905 15% € 30,404
Balance sheet
Balance sheet total € 498,245 25% € 400,196 -3% € 412,932 -1% € 417,636
Equity € 102,580 833% € -14,000 32% € -20,715 44% € -37,027
Debts € 395,665 -4% € 414,195 -4% € 433,647 -5% € 454,664

Publications from Immo-Pharm

Date Publication
17-03-2022 Registered Office - Resignations, Appointments (FR)
05-11-2020 Registered Office - Resignations, Appointments (FR)
23-05-2019 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the enterprise number of Immo-Pharm?
The enterprise number of Immo-Pharm is BE 0726.954.523.
Wat is the PEPPOL ID of Immo-Pharm?
The PEPPOL ID of Immo-Pharm is 0208:0726954523. Log in or start a free trial to see the full overview.
When was Immo-Pharm founded?
Immo-Pharm was founded on 21-05-2019.
What is the address of Immo-Pharm?
The current registered office of Immo-Pharm is located at Place Saint-Pierre 29/1, 1040 Etterbeek.
When was the last time Immo-Pharm filed their annual financial statements?
The most recent financial statements of Immo-Pharm were filed on 01-07-2026.
How many employees does Immo-Pharm have?
There are currently no employees working at Immo-Pharm or no workforce information is available.
What is the annual turnover of Immo-Pharm?
At the time of its most recent financial statements, Immo-Pharm did not publish any turnover figures. Immo-Pharm reported a gross margin of €37,985.20.